Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

ClinicalTrials.gov ID: NCT06212193

Public ClinicalTrials.gov record NCT06212193. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium™ Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).

Study identification

NCT ID
NCT06212193
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Innoventric LTD
Industry
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 5, 2024 (Actual)
Primary completion
Dec 20, 2026 (Estimated)
Completion
Dec 2031 (Estimated)
Last update posted
Nov 4, 2026

2024 – 2031

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Cardiovascular Institute of Los Robles Health System Thousand Oaks California 91360 Recruiting
Ascension St. John Detroit Michigan 48236 Recruiting
Mayo Clinic Hospital (Rochester) Rochester Minnesota 55902 Recruiting
Weill Cornell Medicine New York New York 10065 Recruiting
Stony Brook Heart Institute Stony Brook New York 11794 Recruiting
The Christ Hospital Cincinnati Ohio 45219 Recruiting
TriStar Centennial Medical Center Nashville Tennessee 37203 Recruiting
University of Washington Medical Center Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06212193, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2026 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06212193 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →